London, England, 4th Nov 2021, Tower-Bridge broker says that the month of October is known for many things. It’s pumpkin spice latte season, Halloween, and the start of the holiday shopping season. It’s also a major month for travel with people traveling to visit family, going on vacation, or attending events like weddings. For that reason, it can be valuable to look at which stocks are performing well in the industry over time. One way to do this is to generate a list of top performing stocks.
Travel stocks are an overlooked gem amidst the chaos of today’s markets. The industry would be one of few to see growth during a post-pandemic world, as people return to their old passions and vacations once more become affordable options again. Sure, it hasn’t gone smoothly so far but there is no reason why this will always remain how things play out in our future.!
The recent pandemic has shown that it is possible to contain the spread of diseases, and companies in this industry are on track for long term growth. Investing now could provide an excellent return with these stocks poised at their highest levels yet.
Genocea Biosciences Inc. is a biopharmaceutical company that discovers and develops vaccines for infectious diseases, including genital herpes and HPV-related cancers. The Company’s products in clinical trials include GEN-003 for the treatment of genital herpes and GEN-004 to prevent high-risk types of human papillomavirus. It also conducts research on immune system challenges in cancer and infectious disease vaccine development.
The stock is trading at $4.71 per share, which places it well above its average price of around $1 per share over the past five years (and even further away from its 52-week low of $0.82). With sales that have been growing every year since 2014, revenues are now reaching the $100 million mark.
Genocea Biosciences Inc.’s earnings have been growing rapidly as well, now with a P/E ratio of 749.57 and a forward P/E ratio of 234.13, Genocea could be a company to watch in the future.
JetBlue Airways Corporation is an airline that provides low-fare service, mainly to leisure destinations throughout North America, the Caribbean, South America, Central America, and Europe. The Company’s route network focuses on serving underserved markets and its average aircraft utilization rate promotes year-round daily service to approximately 71 cities in 31 states via Boston Logan International Airport (MA), John F. Kennedy International (NY) and Orlando International Airport.
JetBlue Airways Corporation is trading at $22.38 per share, which is above its average price of around $14 per share over the past five years (and also approaching a 52-week high of $24). The company’s earnings have grown rapidly, with an annualized rate of 71.04% and a P/E ratio of 17.13 to go along with growth in book value per share at 17%.
Alaska Air Group Inc., through its subsidiaries, provides scheduled air transportation for passengers and cargo in the United States and internationally. The Company operates in three segments: Alaska, Horizon, and Virgin America. It has strategic partnerships with multiple airlines to increase efficiencies throughout its system.
The stock is trading at $74.27 per share, which is above its average price of around $50 per share over the past five years (and also approaching a 52-week high of $80). The company’s earnings have grown rapidly, at an annualized rate of 20.26% and a P/E ratio of 31.58 to go along with growth in book value per share at 8.77%.
United Continental Holdings Inc. provides services as United Airlines, Inc., providing scheduled passenger air transportation in the United States and internationally, transporting people worldwide through its hubs in Chicago O’Hare International Airport (IL), George Bush Intercontinental Airport (TX) and Denver International Airport (CO). It has strategic partnerships with multiple airlines to increase efficiencies throughout its system.
The stock is trading at $72.87 per share, which is above its average price of around $64 per share over the past five years (and also approaching a 52-week high of $76). The company’s earnings have grown rapidly, with an annualized rate of 27.97% and a P/E ratio of 26.42 to go along with a growth in book value per share at 10.68%.
Disclaimer: Our content is intended to be used for informational purposes only. It is very important to do your own research before making any investment based on your own personal circumstances. You should take independent financial advice from a professional in connection with, or independently research and verify, any information that you find on this article and wish to rely upon, whether for the purpose of making an investment decision or otherwise.
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Glean News journalist was involved in the writing and production of this article.